| Pediatric Prospective Personalized Immune and Target Identification Trial (NCT04859543) | Masaryk University | 2021-02-02 |
| Diagnostic Efficiency of Artificial Intelligence for Surgical Neuropathology (NCT04671368) | Jinsong Wu | 2021-02-01 |
| Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms (NCT04541082) | Jazz Pharmaceuticals | 2020-10-26 |
| Evaluation of Safety and Efficacy of ProHance in Pediatric Patients <2yrs (NCT03750188) | Bracco Diagnostics, Inc | 2018-11-01 |
| SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors (NCT03434262) | St. Jude Children's Research Hospital | 2018-03-05 |
| Diagnostic Assessment of 18F-fluciclovine and 18F-FDG -PET/MRI of Primary Central Nervous System Lymphoma (NCT03188354) | Norwegian University of Science and Technology | 2017-11-01 |
| A Study of Pomalidomide Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors (NCT03257631) | Celgene | 2017-09-18 |
| Retrospective Study of MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS Patients (NCT03147989) | Bracco Diagnostics, Inc | 2017-05-18 |
| Biomarker Analysis of Central Nervous System Tumors (NCT02692898) | National Cancer Institute (NCI) | 2016-02-25 |
| Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab (NCT01931098) | National Cancer Institute (NCI) | 2015-12-10 |
| Retrospective Study of MRI in Pediatric Patients (NCT02291822) | Bracco Diagnostics, Inc | 2014-11-01 |
| Comparison of Contrast Agents for MRI Perfusion Analysis in Brain Tumor Patients (NCT02095353) | University of Nebraska | 2014-09-01 |
| Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastoma (NCT01582152) | M.D. Anderson Cancer Center | 2012-07-01 |
| Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients (NCT01579253) | Ludwig-Maximilians - University of Munich | 2012-04-01 |
| Neurobehavioral Functioning in Pediatric Brain Tumor Patients After Proton Beam Radiation Treatment (NCT01180881) | Massachusetts General Hospital | 2009-10-01 |
| Coproporphyrine Isomers and Methotrexate Elimination (NCT00822432) | Assistance Publique - Hôpitaux de Paris | 2007-10-01 |
| A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients (NCT00329589) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2005-09-01 |
| Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis (NCT00185848) | Sanjiv Sam Gambhir | 2005-04-01 |
| Safety Study of High Dose Temozolomide to Treat Relapsed/Refractory Central Nervous System (CNS) Malignancy (NCT00629187) | Tufts Medical Center | 2004-04-01 |
| EPO906 Plus Radiation Therapy for the Treatment of Cancer Patients (NCT00328458) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2004-02-01 |